Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mexican pharmaceutical prices

Executive Summary

Rep. Waxman (D-Calif.) is expected to use a report by Families USA at his upcoming drug price hearing. The report maintains that prescription drug prices are consistently much higher in the U.S. than in Mexico. Waxman is planning a hearing on two General Accounting Office studies he requested to compare U.S. prescription drug prices with those in Canada and in Europe. GAO's U.S.-Canadian price comparisons, released Oct. 21, found that identical products are priced an average 32% higher in the U.S. than in Canada ("The Pink Sheet" Oct. 26, p. 3). Entitled "Crossing to Mexico: Priced Out of American Health Care," the Families USA report states that "many Americans seek affordable health care in Mexico." For example, the report states that prices in Arizona, Texas and California pharmacies were more than four times higher for Zantac and Tagamet, about four times higher for Ceclor and more than three times higher for Cardizem than in pharmacies directly across the border.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS021839

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel